MX2010002256A - Composiciones polimericas absorbentes con contenido variable de contraiones y sus metodos de preparacion y uso. - Google Patents
Composiciones polimericas absorbentes con contenido variable de contraiones y sus metodos de preparacion y uso.Info
- Publication number
- MX2010002256A MX2010002256A MX2010002256A MX2010002256A MX2010002256A MX 2010002256 A MX2010002256 A MX 2010002256A MX 2010002256 A MX2010002256 A MX 2010002256A MX 2010002256 A MX2010002256 A MX 2010002256A MX 2010002256 A MX2010002256 A MX 2010002256A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- preparation
- polymeric compositions
- absorbent polymeric
- counterion content
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/32—Polymerisation in water-in-oil emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/04—Acids; Metal salts or ammonium salts thereof
- C08F220/06—Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
- C08J3/128—Polymer particles coated by inorganic and non-macromolecular organic compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
- C08F222/10—Esters
- C08F222/1006—Esters of polyhydric alcohols or polyhydric phenols
- C08F222/103—Esters of polyhydric alcohols or polyhydric phenols of trialcohols, e.g. trimethylolpropane tri(meth)acrylate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2300/00—Characterised by the use of unspecified polymers
- C08J2300/14—Water soluble or water swellable polymers, e.g. aqueous gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2333/04—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters
- C08J2333/06—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters of esters containing only carbon, hydrogen, and oxygen, the oxygen atom being present only as part of the carboxyl radical
- C08J2333/08—Homopolymers or copolymers of acrylic acid esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Surgery (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Toxicology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describen polímeros de polielectrolitos reticulados con contriones de enlace que absorben alrededor de 20 veces o más de su masa en solución salina tal como solución salina fisiológica con la condición de que el sodio no exceda el 60% de los contraiones totales enlazados cuando el hidrógeno es el único contraión diferente. Se proporcionan métodos de preparación de los polímeros descritos y para el tratamiento de los sujetos tales como pacientes que necesitan la remoción de fluidos y/o la modulación de iones (por ejemplo, sodio y/o potasio).
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96882007P | 2007-08-29 | 2007-08-29 | |
US96882107P | 2007-08-29 | 2007-08-29 | |
US96881807P | 2007-08-29 | 2007-08-29 | |
PCT/US2008/074861 WO2009029841A1 (en) | 2007-08-29 | 2008-08-29 | Absorbent polymeric compositions with varying counterion content and their methods of preparation and use |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010002256A true MX2010002256A (es) | 2010-06-23 |
Family
ID=40070840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010002256A MX2010002256A (es) | 2007-08-29 | 2008-08-29 | Composiciones polimericas absorbentes con contenido variable de contraiones y sus metodos de preparacion y uso. |
Country Status (8)
Country | Link |
---|---|
US (3) | US20110123604A1 (es) |
EP (3) | EP2601981A1 (es) |
JP (2) | JP2010538016A (es) |
CN (1) | CN101835500B (es) |
AU (1) | AU2008292907A1 (es) |
CA (1) | CA2697803A1 (es) |
MX (1) | MX2010002256A (es) |
WO (3) | WO2009029829A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI3431094T3 (fi) * | 2008-08-22 | 2023-03-20 | Vifor Int Ltd | Silloitettuja kationinvaihtopolymeerejä, koostumuksia ja käyttö hyperkalemian hoidossa |
WO2010022380A2 (en) * | 2008-08-22 | 2010-02-25 | Relypsa, Inc. | Linear polyol stabilized polyfluoroacrylate compositions |
EP2663291A1 (en) * | 2011-01-10 | 2013-11-20 | Sorbent Therapeutics, Inc. | Compositions comprising crosslinked cation- binding polymers and calcium and/or magnesium cations, and uses thereof |
WO2013019891A1 (en) * | 2011-08-01 | 2013-02-07 | St. Hill Pharmaceutical Corporation | Non-digestible capsules for the delivery of fluid absorbing materials |
WO2013106072A1 (en) * | 2012-01-10 | 2013-07-18 | Sorbent Therapeutics, Inc. | Compositions comprising crosslinked cation-binding polymers and uses thereof |
WO2013106086A1 (en) * | 2012-01-10 | 2013-07-18 | Sorbent Therapeutics, Inc. | Compositions comprising crosslinked cation-binding polymers and uses thereof |
WO2013106073A1 (en) * | 2012-01-10 | 2013-07-18 | Sorbent Therapeutics, Inc. | Compositions comprising crosslinked cation-binding polymers and uses thereof |
US20150183908A1 (en) * | 2012-07-19 | 2015-07-02 | Relypsa, Inc. | Compositions comprising crosslinked cation-binding polymers and uses thereof |
GB2519479B (en) * | 2012-07-19 | 2020-05-20 | Relypsa Inc | Compositions comprising crosslinked cation-binding polymers |
BR112015007749A2 (pt) | 2012-10-08 | 2017-07-04 | Relypsa Inc | métodos para tratamento de hipertensão , de hipercaliemia , e de doença renal crônica. |
US9399090B2 (en) * | 2012-12-10 | 2016-07-26 | Medtronic, Inc. | Potassium loaded ion-exchange material for use in a dialysate regeneration system |
CN103393610B (zh) * | 2013-07-05 | 2014-12-24 | 常州方圆制药有限公司 | 一种脂肪胺聚合物盐快速崩解制剂 |
US20160228403A1 (en) * | 2013-10-04 | 2016-08-11 | Tohoku University | Agent for preventing or ameliorating renal dysfunction |
JP6682537B2 (ja) * | 2014-12-22 | 2020-04-15 | ローム アンド ハース カンパニーRohm And Haas Company | 懸濁重合の方法 |
US10342824B2 (en) | 2017-07-17 | 2019-07-09 | Dr. Marlowe's Weight Loss Institute, P.L.L.C. | Supplement for treating side effects of medications which cause metabolic acidosis |
CN114502206A (zh) * | 2019-10-23 | 2022-05-13 | 金伯利-克拉克环球有限公司 | 使用多功能化学剂增加超吸收材料吸收容量 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4143130A (en) * | 1977-08-29 | 1979-03-06 | Warren-Teed Laboratories, Inc. | Method for treating kidney stones |
JPS6025045B2 (ja) * | 1980-03-19 | 1985-06-15 | 製鉄化学工業株式会社 | 塩水吸収能のすぐれたアクリル酸重合体の製造方法 |
DE3239476C2 (de) * | 1981-10-26 | 1984-06-20 | Arakawa Kagaku Kogyo K.K., Osaka | Verfahren zur Herstellung eines festen, trockenen und wasserabsorbierenden harzes |
US4766173A (en) * | 1987-05-11 | 1988-08-23 | Nalco Chemical Company | Method for reducing residual acrylic acid in acrylic acid polymer gels |
US4861849A (en) * | 1988-01-15 | 1989-08-29 | The Dow Chemical Company | Sodium thiosulfate as part of a redox initiator system for the polymerization of water-swellable polymers |
KR910002913A (ko) * | 1989-07-18 | 1991-02-26 | 리챠드 지. 워터맨 | 에리토르베이트를 수-팽창성 중합체의 중합용 산화환원 개시제 시스템의 성분으로 사용하는 방법 |
AU1691895A (en) * | 1994-02-17 | 1995-09-04 | Procter & Gamble Company, The | Porous absorbent materials having modified surface characteristics and methods for making the same |
DE19543366C2 (de) * | 1995-11-21 | 1998-09-10 | Stockhausen Chem Fab Gmbh | Mit ungesättigten Aminoalkoholen vernetzte, wasserquellbare Polymerisate, deren Herstellung und Verwendung |
JP3885130B2 (ja) * | 1996-06-11 | 2007-02-21 | 株式会社大塚製薬工場 | グアニジノ化合物低下剤並びに水分及びカリウムイオン吸着剤 |
JPH10130154A (ja) * | 1996-10-29 | 1998-05-19 | Otsuka Pharmaceut Factory Inc | 腎疾患患者用延命率改善薬 |
GB9711962D0 (en) * | 1997-06-10 | 1997-08-06 | Reckitt & Colmann Prod Ltd | Therapeutically active compositions |
JP2004517066A (ja) * | 2000-11-20 | 2004-06-10 | ダウ グローバル テクノロジーズ インコーポレイティド | 水吸収性ポリマーの生体内での使用 |
ATE337326T1 (de) * | 2002-03-19 | 2006-09-15 | Genzyme Corp | Hemmer des phosphattransports |
US8192758B2 (en) * | 2004-03-30 | 2012-06-05 | Relypsa, Inc. | Ion binding compositions |
US7429394B2 (en) * | 2004-03-30 | 2008-09-30 | Relypsa, Inc. | Ion binding compositions |
KR101228233B1 (ko) * | 2004-03-30 | 2013-01-31 | 리립사, 인크. | 이온 결합 중합체 및 이의 용도 |
US7854924B2 (en) * | 2004-03-30 | 2010-12-21 | Relypsa, Inc. | Methods and compositions for treatment of ion imbalances |
WO2005105068A1 (en) * | 2004-04-15 | 2005-11-10 | Dow Global Technologies Inc. | In vivo stimulation of intestinal transporters for excretion of nitrogenous wastes |
-
2008
- 2008-08-29 CN CN200880112345.9A patent/CN101835500B/zh not_active Expired - Fee Related
- 2008-08-29 JP JP2010523164A patent/JP2010538016A/ja active Pending
- 2008-08-29 US US12/675,705 patent/US20110123604A1/en not_active Abandoned
- 2008-08-29 CA CA2697803A patent/CA2697803A1/en not_active Abandoned
- 2008-08-29 MX MX2010002256A patent/MX2010002256A/es not_active Application Discontinuation
- 2008-08-29 WO PCT/US2008/074847 patent/WO2009029829A1/en active Application Filing
- 2008-08-29 EP EP12194076.1A patent/EP2601981A1/en not_active Withdrawn
- 2008-08-29 WO PCT/US2008/074861 patent/WO2009029841A1/en active Application Filing
- 2008-08-29 EP EP08798991.9A patent/EP2187979B1/en not_active Not-in-force
- 2008-08-29 EP EP12194070.4A patent/EP2583698A1/en not_active Withdrawn
- 2008-08-29 WO PCT/US2008/074848 patent/WO2009029830A1/en active Application Filing
- 2008-08-29 US US12/675,698 patent/US20110091540A1/en not_active Abandoned
- 2008-08-29 US US12/675,689 patent/US20110104212A1/en not_active Abandoned
- 2008-08-29 AU AU2008292907A patent/AU2008292907A1/en not_active Abandoned
-
2014
- 2014-06-18 JP JP2014125040A patent/JP2014208671A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2583698A1 (en) | 2013-04-24 |
US20110104212A1 (en) | 2011-05-05 |
JP2014208671A (ja) | 2014-11-06 |
CN101835500A (zh) | 2010-09-15 |
CN101835500B (zh) | 2014-05-28 |
EP2187979B1 (en) | 2014-09-24 |
WO2009029830A1 (en) | 2009-03-05 |
WO2009029829A1 (en) | 2009-03-05 |
EP2601981A1 (en) | 2013-06-12 |
AU2008292907A1 (en) | 2009-03-05 |
EP2187979A1 (en) | 2010-05-26 |
CA2697803A1 (en) | 2009-03-05 |
US20110091540A1 (en) | 2011-04-21 |
WO2009029841A1 (en) | 2009-03-05 |
JP2010538016A (ja) | 2010-12-09 |
US20110123604A1 (en) | 2011-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010002256A (es) | Composiciones polimericas absorbentes con contenido variable de contraiones y sus metodos de preparacion y uso. | |
EP2671584A3 (en) | Compositions and methods for treating disorders associated with salt or fluid retention | |
MX2010005776A (es) | Nuevos compuestos y composiciones y metodos de uso. | |
MY144351A (en) | Gel adhesive compositions, method of making, and use thereof | |
ITRM20030210A1 (it) | Protesi da impiegarsi nella terapia chirurgica del prolasso | |
WO2006107638A3 (en) | Non-degradable low swelling, water soluble radiopaque hydrogels | |
MX350541B (es) | Materiales y metodos para mejorar la funcion gastrointestinal. | |
HK1108350A1 (en) | Cooling topical patch preparation | |
WO2007055950A3 (en) | Polycation-polyanion complexes, compositions and methods of use thereof | |
ATE554802T1 (de) | Verfahren zum vorspannen und abdecken von bioprothetischem gewebe | |
WO2009129460A3 (en) | Clonidine formulations in a biodegradable polymer carrier | |
UA98802C2 (ru) | Применение композиции для обработки семян, композиция, способ для обработки семян и семена | |
MX2009004038A (es) | Gel de diclofenaco. | |
PL376536A1 (pl) | Kompozycje i sposoby leczenia chorób układu sercowo-naczyniowego | |
NZ616957A (en) | Hemostatic compositions and therapeutic regimens | |
MX2009009417A (es) | Piperidinil-piperidina y piperazinil-piperidina para uso en el tratamiento de diabetes o dolor. | |
WO2008131451A3 (en) | Pva-paa hydrogels | |
WO2011035018A3 (en) | Suicide ready cells | |
WO2009129269A3 (en) | Surgical tensioning assembly and methods of use | |
UA93516C2 (ru) | Способы лечения b-клеточных злокачественных образований c помощью слитой молекулы taci-ig | |
WO2007070725A3 (en) | Device producing and use of microwave energy for thermotherapy | |
MX2008010843A (es) | Composiciones anhidras utiles para lograr un bienestar sexual aumentado. | |
CN207605051U (zh) | 一种中医骨科夹板用固定装置 | |
ECSP088826A (es) | Compuestos heterocíclicos apropiados para tratar trastornos que responden a la modulación del receptor de serotonina 5ht6 | |
WO2009129510A3 (en) | Sulindac formulations in a biodegradable material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |